Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Concentrations: Measurements

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...

Drug Classes and Categories

Drug Classes and Categories

Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Drug Toxicity: Overview

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

Drug Toxicity: Risk factors

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cause and manner of death and phase of the blood alcohol curve.

Forensic science international·2014

Same author

Fatal poisonings in Finland during the years 2004-2009.

Human & experimental toxicology·2013

Same author

Fatal poisoning in drug addicts in the Nordic countries in 2007.

Forensic science international·2010

Same author

Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry.

Forensic science international·2009

Same author

Stimulating and inhibitory effects of the dopamine "stabilizer" (-)-OSU6162 on dopamine D2 receptor function in vitro.

Journal of neural transmission (Vienna, Austria : 1996)·2007

Same author

Recurrent opioid toxicity after pre-hospital care of presumed heroin overdose patients.

Acta anaesthesiologica Scandinavica·2006

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Blood-positive illicit-drug findings: implications for cause-of-death certification, classification and coding.

R A Lahti¹, H Korpi, E Vuori

¹Department of Forensic Medicine, University of Helsinki, Helsinki, Finland. raimo.lahti@kolumbus.fi

Forensic Science International

|March 24, 2009

Summary

Drug intoxication is often underrepresented in official cause-of-death statistics, especially for cannabinoids and amphetamines. Improved coding systems are needed for accurate drug-related death classification and trends.

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS

Published on: November 8, 2024

Related Experiment Videos

Last Updated: Jun 24, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS

Published on: November 8, 2024

Area of Science:

Public Health
Toxicology
Medical Informatics

Background:

National cause-of-death data are crucial for public health administration, international comparisons, and epidemiological research.
Accurate mortality statistics rely on precise determination, certification, coding, and selection of the underlying cause of death.

Purpose of the Study:

To assess the specificity and unequivocal representation of toxicologically verified drug intoxications (cannabinoids, opiates, amphetamines, cocaine) in death certificates and national databases.
To evaluate the accuracy of drug-related causes of death in official statistics.

Main Methods:

Reviewed drug-positive deaths, death certificates, and Statistics Finland's cause-of-death database for 2000, 2002, and 2004.
Analyzed the representation of drug-related conditions as causes of death and specific drug diagnoses in the database.
Examined the coding of drug-related causes in cause-of-death statistics, including multiple-drug cases and ICD-10 coding.

Main Results:

Drug-related conditions were reported as causes of death in 52% (cannabinoids) to 100% (cocaine) of drug-positive deaths.
Specific drug-related diagnoses were identified in the cause-of-death database for 21% (cannabinoids) to 89% (opiates) of cases.
Specific drug-related underlying causes in statistics were even lower for cannabinoids (10%) and amphetamines (39%); unspecific ICD-10 codes were common.

Conclusions:

Toxicologically verified drug intoxications are often not specifically or unequivocally represented in official cause-of-death statistics.
Current ICD-10 coding limitations hinder accurate classification of drug-related deaths, particularly for cannabinoids and amphetamines.
Propose revisions to ICD, such as drug-specific codes (e.g., ATC-like), to improve the specificity and comparability of drug-related mortality data.